ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg/ml - rituximab - rituximab - mabthera is indicated for the following indications: * non-hodgkin’s lymphoma (nhl)mabthera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, b-cell non-hodgkin’s lymphoma.mabthera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy mabthera is indicated for the treatment of patients with cd20 positive diffuse large b-cell non-hodgkin's lymphoma in combination with chop chemotherapy. mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * chronic lymphocytic leukaemia (cll)mabthera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including mabthera or patients refractory to previous mabthera plu

ישראל - עברית - Ministry of Health

ofek pharma ltd, israel - posaconazole - טבליות שחרור מושהה - posaconazole 100 mg - posaconazole

ישראל - עברית - Ministry of Health

dor pharmaceutical services ltd., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 100 mg/vial - bendamustine

ישראל - עברית - Ministry of Health

astellas pharma international b.v., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 100 mg - bendamustine

ישראל - עברית - Ministry of Health

dor pharmaceutical services ltd., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 25 mg/vial - bendamustine

ישראל - עברית - Ministry of Health

astellas pharma international b.v., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 25 mg - bendamustine

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - rituximab - תמיסה להזרקה - rituximab 1400 mg / 11.7 ml - rituximab

ישראל - עברית - Ministry of Health

novartis israel ltd - fludarabine phosphate - תרכיז להכנת תמיסה לאינפוזיה\הזרקה - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - obinutuzumab - תרכיז להכנת תמיסה לאינפוזיה - obinutuzumab 1000 mg / 40 ml - obinutuzumab

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - טבליות מצופות פילם - voriconazole 50 mg - voriconazole - voriconazole - treatment of: invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) serious fungal infections caused by scedosporium spp. and fusarium spp. vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.